Spironolactone is a medication that is often used as part of feminizing hormone therapy for transgender women. However, it is not considered a direct form of hormone replacement therapy (HRT). Here's an overview of what spironolactone is and why it's often included as part of transgender HRT:
Spironolactone is classified as an anti-androgen medication. It works by blocking receptors for testosterone and dihydrotestosterone (DHT), the body's main masculinizing hormones. By blocking these receptors, spironolactone reduces the effects of any testosterone or DHT still present while a trans woman is transitioning.
Some key facts about spironolactone:
Here are some key reasons spironolactone is often included as part of a transfeminine HRT regimen:
So in summary - spironolactone itself does not contain any female sex hormones. However, it acts as a powerful indirect feminizing agent when paired alongside standard estrogen HRT. It blocks testosterone receptors, reduces masculine characteristics, and allows estrogen's effects to fully surface. These effects are so impactful that spironolactone is considered a standard, almost essential part of transfeminine HRT in most cases.
If you are interested in exploring feminizing hormone therapy options including estrogen, spironolactone and progesterone, the caring physicians at () can help. Our experts specialize in LGBTQ healthcare, with years of experience safely and effectively treating transgender patients.
We provide fully customized HRT regimens tailored to your unique goals, needs and bloodwork. Rather than taking a one-size-fits-all approach, we'll design a feminizing plan that helps you achieve maximum results as comfortably as possible.
To learn more or schedule a risk-free consultation, visit () today!